Sign in

You're signed outSign in or to get full access.

Alan Goodson

President at abrdn World Healthcare Fund
Executive

About Alan Goodson

Alan Goodson (born 1974) serves as President of abrdn World Healthcare Fund (THW) and the affiliated abrdn healthcare closed-end funds, a role he has held since 2023. He is Director, Vice President, and Head of Product & Client Solutions—Americas at abrdn Inc., overseeing Product Management & Governance, Product Development, and Client Solutions across the U.S., Brazil, and Canada; he joined abrdn in 2000 . Officers of the Funds are employees of abrdn Inc. and do not receive compensation from the Funds; the proxy discloses no fund-level performance-linked compensation metrics for officers . As of April 1, 2025, Goodson beneficially owned between $1–$10,000 of HQH; the proxy does not disclose THW holdings for him, and officers/trustees collectively owned less than 1% of each Fund’s outstanding equity securities .

Past Roles

OrganizationRoleYearsStrategic Impact
abrdn Inc.Director, Vice President, Head of Product & Client Solutions—Americas2000–presentOversees Product Management & Governance, Product Development, and Client Solutions for registered/unregistered investment companies in U.S., Brazil, and Canada
abrdn World Healthcare Fund (THW) and related FundsPresidentSince 2023Executive officer capacity for the Funds within the abrdn fund complex

External Roles

OrganizationRoleYearsStrategic Impact
Not disclosed in proxyThe proxy lists trustees’ other directorships but provides no external roles for Goodson (officer)

Fixed Compensation

ComponentDisclosureNotes
Fund-paid base salaryNot applicableOfficers are employees of and compensated by abrdn Inc.; no officer is paid by the Funds
Fund-paid annual bonusNot applicableNone of the Funds have bonus, profit sharing, pension, or retirement plans
Fund-paid benefits/perquisitesNot applicableNo fund-level officer compensation programs disclosed

Performance Compensation

MetricWeightingTargetActualPayoutVesting
Not disclosed for officersFunds disclose no performance-linked compensation plans for officers; officers are compensated by abrdn Inc.

Equity Ownership & Alignment

ItemValueNotes
Goodson beneficial ownership (HQH)$1–$10,000As of April 1, 2025; no THW-specific ownership disclosed for Goodson in proxy
Officers/trustees aggregate ownership<1% of each FundAs of April 1, 2025
THW shares outstanding39,849,957.6Record Date April 7, 2025
Section 16 reportingLate Form 4 for Goodson (HQH purchase)Indicates an open-market purchase; filing was late per proxy disclosure (administrative compliance note)

Employment Terms

Term ElementProvisionSource
Officer appointmentOfficers are appointed annually at a meeting of the Fund Board
Tenure mechanicsOfficers hold their positions until a successor has been duly elected and qualifies
Severance / Change-of-controlNot disclosed for officers in proxy
Clawbacks / Tax gross-upsNot disclosed for officers in proxy

Investment Implications

  • Pay-for-performance visibility at the fund level is low for officers: compensation is set and paid by abrdn Inc., and the Funds disclose no officer-level cash or equity programs, metrics, or vesting tied to THW performance, limiting direct alignment signals from fund filings .
  • Skin-in-the-game appears modest in the filings: Goodson’s disclosed beneficial ownership relates to HQH ($1–$10,000), while THW-specific ownership is not disclosed; officers and trustees collectively owned <1% of each Fund, suggesting limited direct ownership alignment via fund shares .
  • Compliance note: a late Form 4 for Goodson on an HQH purchase indicates an administrative lapse rather than selling pressure; it does not signal insider selling in THW based on proxy disclosures .
  • Retention risk looks contained: Goodson’s long tenure at abrdn (since 2000) and current senior product/client solutions responsibilities suggest organizational embeddedness, though employment contract economics (severance, change-of-control) are not disclosed by the Funds .